Jennifer C. Price’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$166K Sell
4,000
-1,000
-20% -$47.8K 0.22% 24
2024
Q3
$413K Buy
5,000
+3,000
+150% +$275K 0.46% 21
2024
Q2
$238K Hold
2,000
0.28% 30
2024
Q1
$213K Buy
2,000
+1,000
+100% +$101K 0.2% 31
2023
Q4
$99.5K Hold
1,000
0.07% 44
2023
Q3
$103K Buy
+1,000
New +$112K 0.06% 44

Other funds holding MRNA

Jennifer C. Price's MRNA Position: Q4 2024 in Review

Jennifer C. Price reduced its Moderna (MRNA) stake by 20% in Q4 2024, selling an estimated $47.8K and leaving 4,000 shares worth $166K. The position accounts for 0.22% of the portfolio, ranked #24.

Jennifer C. Price first reported a position in MRNA in Q3 2023 and has held it in 6 quarters since. The position peaked at $413K in Q3 2024. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Jennifer C. Price held 4,000 shares of Moderna worth $166K as of Q4 2024.
  • Jennifer C. Price sold 1,000 Moderna shares in Q4 2024, an estimated $47.8K.
  • Moderna made up 0.22% of Jennifer C. Price's portfolio in Q4 2024, its #24 holding.
  • Jennifer C. Price first reported a position in Moderna in Q3 2023 and has held it in 6 quarters since.
  • Jennifer C. Price's Moderna position peaked at $413K in Q3 2024.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Jennifer C. Price's 13F filing for Q4 2024, filed 13 Feb 2025.